Mixture

Hazard statements (CLP)

H315, H317, H319, H334, H335, H351, H373

Code

Statements

H315

Causes skin irritation

SECTION 2: Hazards identification

2.1 Classification of the substance or mixture

H317 Skin sensitisation, Category 1 Carcinogenicity, Category 2 H317 H351 Carcinogenicity, Category 2 Specific target organ toxicity – Single exposure, Category 3, H351 H335 Specific target organ toxicity – Single exposure, Category 3, Respiratory tract irritation H335 Respiratory tract irritation Specific target organ toxicity – Repeated exposure, Category 2 H373 Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects Suspected of causing cancer. May cause damage to organs through prolonged or repeated exposure. May cause respiratory irritation. Causes skin irritation. May cause an allergic skin reaction. Causes serious eye irritation. May cause allergy or asthma symptoms or breathing difficulties if inhaled. 2.2. Label elements Labelling according to Regulation (EC) No. 1272/2008 [CLP] Hazard pictograms (CLP) : Hazard pictograms (CLP) : GHS07 GHS08 Signal word (CLP) GHS07 GHS08 : Danger Signal word (CLP) Contains : Danger : Oxirane, methyl-, polymer with oxirane, ether with 1,2,3-propanetriol (3:1), polymer with 1,1- Contains

Adverse physicochemical, human health and environmental effects

Suspected of causing cancer. May cause damage to organs through prolonged or repeated exposure. May cause respiratory irritation. Causes skin irritation. May cause an allergic skin reaction. Causes serious eye irritation. May cause allergy or asthma symptoms or breathing difficulties if inhaled

Hazard pictograms

GHS07 GHS08

Signal word

GHS07 GHS08 Danger

Contains

Danger Oxirane, methyl-, polymer with oxirane, ether with 1,2,3-propanetriol (3:1), polymer with 1,1- Oxirane, methyl-, polymer with oxirane, ether with 1,2,3-propanetriol (3:1), polymer with 1,1- methylenebis4-isocyanatobenzene; 4-isocyanatosulphonyltoluene; tosyl isocyanate

Hazard statements

methylenebis4-isocyanatobenzene; 4-isocyanatosulphonyltoluene; tosyl isocyanate H315 - Causes skin irritation. H315 - Causes skin irritation. H317 - May cause an allergic skin reaction. H317 - May cause an allergic skin reaction. H319 - Causes serious eye irritation. H319 - Causes serious eye irritation. H334 - May cause allergy or asthma symptoms or breathing difficulties if inhaled. 12/21/2024 (Revision date) GB - en 12/21/2024 (Revision date) H335 - May cause respiratory irritation. H351 - Suspected of causing cancer. H373 - May cause damage to organs through prolonged or repeated exposure.

Precautionary statements

P201 - Obtain special instructions before use. P261 - Avoid breathing dust/fume/gas/mist/vapours/spray. P264 - Wash hands, forearms and face thoroughly after handling. P280 - Wear eye protection, protective clothing, protective gloves. P304+P340 - IF INHALED: Remove person to fresh air and keep comfortable for breathing. P308+P313 - IF exposed or concerned: Get medical advice/attention. P312 - Call a POISON CENTRE or doctor if you feel unwell. P321 - Specific treatment (see supplemental first aid instruction on this label). P342+P311 - If experiencing respiratory symptoms: Call a POISON CENTER or doctor.

Supplemental label elements

EUH212 - Warning! Hazardous respirable dust may be formed when used. Do not breathe dust.

Additional information

As from 24 August 2023 adequate training is required before industrial or professional use.

2.3 Other hazards

This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %